Dear Respected Users,
Hotbit is scheduled to list DOGEK(Doge King) on Global Section.
Deposit function launches at: 2021.11.12 08:00 AM UTC
Trading function launches at: 2021.11.12 10:00 AM UTC
Trading Pair: DOGEK/nUSD
Note: According to the mechanism of DOGEK 's contract, each transfer will be deducted 8% transfer fees on chain, which means that the actual volume of DOGEK that the users will receive as deposit = The volume of DOGEK that the users initially transferred - 8% of transfer transaction fee deducted on-chain.
The actual volume of DOGEK that the users will receive as withdrawal = The volume of DOGEK that the users initially transferred - the DOGEK withdrawal fees on Hotbit - 8% transfer transaction fee deducted on-chain.
For further details regarding the mechanism of DOGEK contract, please feel free to contact DOGEK’s official team.
【Hotbit users exclusively enjoy “Minus Maker Means Minus Transaction Fee” mechanism. By placing and settling any maker order, the user will enjoy 0 transaction fee and an extra 0.30% of the trading volume of his/her maker order as reward on Global Section!】
Project Name: Doge King
Abbreviation: DOGEK
Project Introduction:
Doge King is a MEME & Self Solvent Token on #BSC inspired by #DOGE Coin.
Token type: BEP-20
Total supply: 845,000,000,000,000 DOGEK
Circulating supply: 845,000,000,000,000 DOGEK
Official Website: https://dogekingtoken.com
Explorer：https://bscscan.com/token/0x01db446f7c6d20ce1fca421b4397da789fbb21f1
Risk warning
The investment on cryptocurrency projects is subject to high market risks. Please make your investments cautiously. Hotbit will make best efforts to choose the cryptocurrency projects with high quality, but Hotbit will not be responsible for any of your investment losses.
Thank you for your support！
Yours truly
Hotbit Team
About us ：
Hotbit’s Official Website： https://www.hotbit.io/
Telegram ： https://t.me/Hotbit_English
Twitter： https://twitter.com/Hotbit_news
Facebook： https://www.facebook.com/hotbitexchange/
Medium： https://medium.com/@hotbit
Comments
0 comments
Article is closed for comments.